Table 2.
Patients outcomes
| LTGN (n = 21) | LATLSN (n = 32) | P value | |
|---|---|---|---|
| Mortality, n | 2 | 3 | 1.00 |
| Postoperative morbidity, n | 6a | 17b | 0.04 |
| Hemorrhage | 2 | 3 | |
| Pancreatic fistula | 0 | 12 | |
| Intra-abdominal infection | 3 | 3 | |
| Enterocutaneous fistula | 1 | 1 | |
| Clavien–Dindo ≥ III complications, n | 4 | 4 | 0.70 |
| Additional percutaneous drainage, n | 2 | 2 | 1.00 |
| Additional surgery, n | 3 | 5 | 1.00 |
| ICU stay (days) | 6 (2–32) | 5 (1–21) | 0.76 |
| Postoperative hospital stay (days) | 13 (6–43) | 11 (6–38) | 0.45 |
| Recurrent WON, n | 2 | 2 | 1.00 |
| Repeated surgery, n | 1 | 1 | 1.00 |
| Long-term complications, n | 5 | 10 | 0.56 |
| New-onset diabetes | 3 | 3 | |
| Pancreatic exocrine insufficiency | 2 | 3 | |
| Incisional hernia | 0 | 0 |
aTwo patients in LTGN group had multiple complications, one with hemorrhage and colonic fistula, and another with hemorrhage and intra-abdominal infection
bTwo patients were complicated with hemorrhage and pancreatic fistula